company background image
BNXT logo

BioNxt Solutions CNSX:BNXT Stock Report

Last Price

CA$0.46

Market Cap

CA$52.4m

7D

-14.8%

1Y

-35.2%

Updated

26 Mar, 2024

Data

Company Financials

BNXT Stock Overview

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, the United States, and Canada.

BNXT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

BioNxt Solutions Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioNxt Solutions
Historical stock prices
Current Share PriceCA$0.46
52 Week HighCA$0.75
52 Week LowCA$0.25
Beta0.61
1 Month Change-26.98%
3 Month Change-13.21%
1 Year Change-35.21%
3 Year Change-82.96%
5 Year Changen/a
Change since IPO-54.00%

Recent News & Updates

Recent updates

Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

Oct 27
Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

BioNxt Solutions (CSE:BNXT) Is Making Moderate Use Of Debt

Nov 30
BioNxt Solutions (CSE:BNXT) Is Making Moderate Use Of Debt

Is XPhyto Therapeutics (CSE:XPHY) A Risky Investment?

Aug 03
Is XPhyto Therapeutics (CSE:XPHY) A Risky Investment?

Shareholder Returns

BNXTCA PharmaceuticalsCA Market
7D-14.8%4.7%0.2%
1Y-35.2%39.5%9.0%

Return vs Industry: BNXT underperformed the Canadian Pharmaceuticals industry which returned 30.4% over the past year.

Return vs Market: BNXT underperformed the Canadian Market which returned 9.3% over the past year.

Price Volatility

Is BNXT's price volatile compared to industry and market?
BNXT volatility
BNXT Average Weekly Movement12.8%
Pharmaceuticals Industry Average Movement13.5%
Market Average Movement8.6%
10% most volatile stocks in CA Market18.5%
10% least volatile stocks in CA Market3.1%

Stable Share Price: BNXT's share price has been volatile over the past 3 months.

Volatility Over Time: BNXT's weekly volatility (13%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aHugh A. Rogershttps://www.bionxt.com

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, the United States, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors.

BioNxt Solutions Inc. Fundamentals Summary

How do BioNxt Solutions's earnings and revenue compare to its market cap?
BNXT fundamental statistics
Market capCA$52.45m
Earnings (TTM)-CA$12.62m
Revenue (TTM)CA$388.85k

129.3x

P/S Ratio

-4.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BNXT income statement (TTM)
RevenueCA$388.85k
Cost of RevenueCA$144.27k
Gross ProfitCA$244.59k
Other ExpensesCA$12.86m
Earnings-CA$12.62m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.12
Gross Margin62.90%
Net Profit Margin-3,244.46%
Debt/Equity Ratio-121.0%

How did BNXT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.